Contract with Customer, Liability, Current of Can-Fite BioPharma Ltd. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary: Can-Fite BioPharma Ltd. quarterly Contract with Customer, Liability, Current in USD history and change rate from 31 Dec 2022 to 30 Jun 2025.
Can-Fite BioPharma Ltd. Contract with Customer, Liability, Current for the quarter ending 30 Jun 2025 was $405,000, a 36% decline year-over-year.
Source SEC data: View on sec.gov

Contract with Customer, Liability, Current, Quarterly (USD)

Contract with Customer, Liability, Current, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Contract with Customer, Liability, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$405,000	-$231,000	-36%	30 Jun 2025	6-K	28 Aug 2025	2025	Q2
Q4 2024	$405,000	-$217,000	-35%	31 Dec 2024	6-K	28 Aug 2025	2025	Q2
Q2 2024	$636,000			30 Jun 2024	6-K	29 Aug 2024	2024	Q2
Q4 2023	$622,000	-$161,000	-21%	31 Dec 2023	20-F	14 Apr 2025	2024	FY
Q4 2022	$783,000			31 Dec 2022	20-F	28 Mar 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.